Implantica AG (IPLTF)
OTCMKTS · Delayed Price · Currency is USD
6.24
0.00 (0.00%)
Sep 15, 2026, 9:30 AM EST
Implantica AG Revenue
Implantica AG had revenue of 717.00K EUR in the quarter ending June 30, 2026, with 65.59% growth. This brings the company's revenue in the last twelve months to 2.47M, up 25.71% year-over-year. In the year 2025, Implantica AG had annual revenue of 2.07M with 7.08% growth.
Revenue (ttm)
2.47M EUR
Revenue Growth
+25.71%
P/S Ratio
597.66
Revenue / Employee
53.67K EUR
Employees
46
Market Cap
1.69B USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.07M | 137.00K | 7.08% |
| Dec 31, 2024 | 1.94M | 528.00K | 37.50% |
| Dec 31, 2023 | 1.41M | 566.00K | 67.22% |
| Dec 31, 2022 | 842.00K | 455.00K | 117.57% |
| Dec 31, 2021 | 387.00K | 235.00K | 154.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 36.88M |
| Sonendo | 31.70M |
| Kelyniam Global | 2.67M |
| BioElectronics | 1.61M |
| PetVivo Holdings | 1.18M |
| Guided Therapeutics | 650.00K |
| Positron | 444.82K |
| Vivos | 99.10K |
Implantica AG News
- 14 days ago - Implantica's Capital Markets Day webcast available on demand - PRNewsWire